Literature DB >> 31439282

Prevalence and Predictors of Coronary Artery Perforation During Percutaneous Coronary Interventions (from the ORPKI National Registry in Poland).

Tomasz Rakowski1, Michał Węgiel2, Zbigniew Siudak3, Krzysztof Plens4, Artur Dziewierz2, Ralf Birkemeyer5, Paweł Kleczyński2, Tomasz Tokarek2, Łukasz Rzeszutko6, Dariusz Dudek2.   

Abstract

Coronary artery perforation (CAP) is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). With a growing number of PCIs in complex lesions, the problem of CAP becomes even more important nowadays. Data on CAP rates in Poland are lacking. Presented study is an analysis of 344,517 consecutive patients treated with PCI between 2014 and 2017. Data were gathered from the Polish National PCI Registry (ORPKI). During 4 years of data collection CAP was observed in 595 (0.17%) cases. Patients diagnosed with CAP were older (69 years Q1:63; Q3:78 vs 66 years Q1:60; Q3:75; p <0.001), more often female (44% vs 32%; p <0.001), with arterial hypertension (77% vs 71%; p = 0.002), and chronic kidney disease (8.9% vs 5.4%; p <0.001). In the CAP group, a higher rate of PCIs within chronic total occlusions (8.7% vs 2.3%; p <0.001) and saphenous vein graft lesions (2.7% vs 1.3%; p = 0.002), as well as rotational atherectomy procedures (2.2% vs 0.4%; p <0.001) was observed. Patients with CAP had higher rate of no-reflow phenomenon (5.5% vs 0.5%; p <0.001) and greater periprocedural mortality (4.2% vs 0.5%; p <0.001). In conclusion, our study confirms that CAP is more common during complex PCI procedures in high-risk patients. CAP occurrence is associated with worse immediate outcomes including increased periprocedural mortality.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31439282     DOI: 10.1016/j.amjcard.2019.07.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Clinical Outcomes of Self-Made Polyurethane-Covered Stent Implantation for the Treatment of Coronary Artery Perforations.

Authors:  Xiaoyue Song; Qing Qin; Shufu Chang; Rende Xu; Mingqiang Fu; Hao Lu; Lei Ge; Juying Qian; Jianying Ma; Junbo Ge
Journal:  J Interv Cardiol       Date:  2021-05-17       Impact factor: 2.279

2.  Incidence and Mechanisms of Coronary Perforations during Rotational Atherectomy in Modern Practice.

Authors:  Yen-Hsiang Wang; Wei-Jhong Chen; Yu-Wei Chen; Chih-Hung Lai; Chieh-Shou Su; Wei-Chun Chang; Chi-Yen Wang; Kae-Woei Liang; Tsun-Jui Liu; Wen-Lieng Lee
Journal:  J Interv Cardiol       Date:  2020-11-10       Impact factor: 2.279

3.  Procedural and 1-year outcomes following large vessel coronary artery perforation treated by covered stents implantation: Multicentre CRACK registry.

Authors:  Wojciech Wańha; Rafał Januszek; Michalina Kołodziejczak; Łukasz Kuźma; Mateusz Tajstra; Tomasz Figatowski; Malwina Smolarek-Nicpoń; Monika Gruz-Kwapisz; Brunon Tomasiewicz; Jerzy Bartuś; Andrzej Łoś; Dariusz Jagielak; Tomasz Roleder; Adrian Włodarczak; Jan Kulczycki; Mariusz Kowalewski; Damian Hudziak; Paweł Stachowiak; Jarosław Gorący; Katarzyna Sierakowska; Krzysztof Reczuch; Miłosz Jaguszewski; Sławomir Dobrzycki; Grzegorz Smolka; Stanisław Bartuś; Andrzej Ochała; Mariusz Gąsior; Wojciech Wojakowski
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

4.  Changing trends in the incidence, management and outcomes of coronary artery perforation over an 11-year period: single-centre experience.

Authors:  Hamza Umar; Harish Sharma; Mohammed Osheiba; Ashwin Roy; Peter F Ludman; Jonathan N Townend; M Adnan Nadir; Sagar N Doshi; Sudhakar George; Alex Zaphiriou; Sohail Q Khan
Journal:  Open Heart       Date:  2022-04

5.  Multi-Center Experience of Coronary Artery Perforation During Percutaneous Coronary Intervention: Clinical and Angiographic Characteristics, Management, and Outcomes Between 2010 and 2020.

Authors:  Ramazan Gündüz; Bekir Serhat Yıldız; Nurullah Çetin; Su Özgür; Ahmet Yaşar Çizgici; Kamil Tülüce; Selcen Yakar Tülüce; Mehmet Burak Özen; Soner Duman; Özgür Bayturan
Journal:  Anatol J Cardiol       Date:  2022-08       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.